Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1
    Meeting Abstract

    Friedlander, M. L.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: What is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study
    Journal Article

    Liu, Y. L.; Zhou, Q. C.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G.; Broach, V.; O'Cearbhaill, R.; Konner, J. A.; more...
    International Journal of Gynecological Cancer (2020)

    Fulltext@MSK | Save
  • Population exposure-safety and exposure-efficacy analyses for rucaparib in patients (pts) with recurrent ovarian carcinoma (rOC) from Study 10 and ARIEL2
    Meeting Abstract

    Konecny, G. E.; Oza, A. M.; Tinker, A. V.; Oaknin, A.; Shapira-Frommer, R.; Ray-Coquard, I.; Aghajanian, C.; Coleman, R. L.; O'Malley, D. M.; Leary, A.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Postprogression outcomes in patients with ovarian carcinoma associated with amutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3
    Meeting Abstract

    O'Malley, D. M.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes of newly diagnosed stage II ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab
    Meeting Abstract

    Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Optimizing number of preoperative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; Konner, J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Exploring the relationship between homologous recombination score and progression-free survival in BRCA wildtype ovarian carcinoma: Analysis of veliparib plus carboplatin/paclitaxel in the velia study
    Meeting Abstract

    Swisher, E. M.; Kaufmann, S. H.; Birrer, M. J.; Levine, D. A.; Moore, K. N.; Fleming, G. F.; Coleman, R. L.; Bookman, M. A.; Timms, K. M.; Sullivan, D. M.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Anti-tumor activity of veliparib during combination phase with chemotherapy in velia study
    Meeting Abstract

    O'Malley, D. M.; Bookman, M. A.; Moore, K. N.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Aghajanian, C.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Mutation detection in cell-free DNA using ultra-high depth sequencing in prospectively collected newly diagnosed endometrial cancer patients
    Meeting Abstract

    Ashley, C. W.; Brown, D.; Lakhman, Y.; Nincevic, J.; Stylianou, A.; Wu, M.; Selenica, P.; Patel, J. A.; Berger, M. F.; Leitao, M. M. Jr; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, and whole populations from the velia trial
    Meeting Abstract

    Swisher, E. M.; Coleman, R. L.; Bookman, M. A.; Brady, M. F.; Fleming, G. F.; Friedlander, M.; Cunningham, M. J.; Tewari, K. S.; Edraki, B.; Moxley, K.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save